General presentation of Alcon
As an investor, you must also have a perfect knowledge of Alcon and its specificities before you start trading in this security. This requires in particular a good knowledge of the main products marketed by this company and its main sources of income.
The Alcon group is a Swiss company which operates in the pharmaceutical sector. More specifically, this company is currently the world leader in the design, production and sale of eye care products.
To better understand the activities of this company, we can divide them into different categories according to the share of turnover they generate and in this way:
- Ophthalmic surgical products and equipment represent 56.7% of the group's turnover with consumables, implantable products or even surgical equipment intended for the treatment of cataracts, retinal diseases, glaucoma and refractive errors.
- Vision care products generate 43.3% of the company's turnover with contact lenses, eye care products, eye drops or ophthalmic ointments.
Currently, the Alcon group owns and operates 18 different production sites around the world.
From a geographic point of view, Alcon achieves only 0.8% of its turnover in Switzerland. Its largest market is the American market with 41.5% of turnover. Next comes Japan with 8.9% of turnover and the rest of the world for 48.8%.
67% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on eToro